- Fund Type: Open-End Fund
- Objective: Index Fund
- Asset Class: Equity
- Geographic Focus: Israel
Snapshot for Analyst TA25 (ANLTA25)
| Year To Date: | +2.76% | 3-Month: | -1.42% | 3-Year: | -2.09% | 52-Week Range: | 154.50 - 191.99 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +1.50% | 1-Year: | +10.60% | 5-Year: | -1.44% | Beta vs TA-25: | 1.00 |
Fund Profile & Information for ANLTA25
Analyst TA25 is an open-end fund registered in Israel.
| Inception Date: | 09-01-2004 | Telephone: | 972-3-7147147 Tel |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | - | ||
Fundamentals for ANLTA25
| NAV | (on 2013-05-20) 187.98 |
|---|---|
| Assets (M) | (on 2013-04-30) 7.50 |
| Fund Leveraged | N |
| Minimum Investment | - |
| Minimum Subsequent Investment | - |
Dividends for ANLTA25
No dividends reported
Fees & Expenses for ANLTA25
| Front Load | - |
|---|---|
| Back Load | - |
| Current Mgmt Fee | 3.80 |
| Redemption Fee | - |
| 12b1 Fee | - |
| Expense Ratio | - |
Top Fund Holdings for ANLTA25
Filing Date: 01/31/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Bank Hapoalim BM | 51,000 | 796,110 | 10.070% |
| Bank Leumi Le-Israel BM | 63,000 | 778,680 | 9.850% |
| Israel Chemicals Ltd | 14,500 | 712,530 | 9.013% |
| Teva Pharmaceutical Industries | 4,600 | 633,880 | 8.018% |
| Perrigo Co | 1,400 | 514,920 | 6.513% |
| Israel Corp Ltd/The | 160 | 405,120 | 5.125% |
| Bezeq The Israeli Telecommunic | 93,000 | 404,829 | 5.121% |
| Mellanox Technologies Ltd | 2,000 | 378,000 | 4.781% |
| Elbit Systems Ltd | 2,500 | 356,000 | 4.503% |
| Delek Group Ltd | 360 | 328,680 | 4.158% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page